Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cutland

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
Vaccine|November 19, 2017
Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety dataClare L Cutland, Eve M Lackritz, Tamala Mallett-Moore, et al.
The Lancet. HIV|January 9, 2020
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trialMarta C Nunes, Clare L Cutland, Andrew Moultrie, et al.
The Lancet. Infectious Diseases|May 4, 2016
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trialShabir A Madhi, Clare L Cutland, Lisa Jose, et al.
Vaccine|May 26, 2020
Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant womenLinda O Eckert, Christine E Jones, Alisa Kachikis, et al.
Medicine|January 13, 2017
Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV statusShabir A Madhi, Anthonet Koen, Lisa Jose, et al.
Vaccine: X|August 14, 2025
Corrigendum to "Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review". [Vaccine X, 2024 Feb 23;18:100464]Hannah G Davies, Emma V Thorley, Rossul Al-Bahadili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During PregnancyShabir A Madhi, Anthonet Koen, Clare L Cutland, et al.
The Lancet. Infectious Diseases|February 13, 2016
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trialRobert S Heyderman, Shabir A Madhi, Neil French, et al.
Vaccine: X|March 18, 2024
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic reviewHannah G Davies, Emma V Thorley, Rossul Al-Bahadili, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
Vaccine|November 19, 2017
Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety dataClare L Cutland, Eve M Lackritz, Tamala Mallett-Moore, et al.
The Lancet. HIV|January 9, 2020
Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trialMarta C Nunes, Clare L Cutland, Andrew Moultrie, et al.
The Lancet. Infectious Diseases|May 4, 2016
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trialShabir A Madhi, Clare L Cutland, Lisa Jose, et al.
Vaccine|May 26, 2020
Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant womenLinda O Eckert, Christine E Jones, Alisa Kachikis, et al.
Medicine|January 13, 2017
Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV statusShabir A Madhi, Anthonet Koen, Lisa Jose, et al.
Vaccine: X|August 14, 2025
Corrigendum to "Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review". [Vaccine X, 2024 Feb 23;18:100464]Hannah G Davies, Emma V Thorley, Rossul Al-Bahadili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During PregnancyShabir A Madhi, Anthonet Koen, Clare L Cutland, et al.
The Lancet. Infectious Diseases|February 13, 2016
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trialRobert S Heyderman, Shabir A Madhi, Neil French, et al.
Vaccine: X|March 18, 2024
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic reviewHannah G Davies, Emma V Thorley, Rossul Al-Bahadili, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
Pageof 18